The mission of the BTTC is to develop and perform hypothesis-based, state-of-the-art clinical trials in a collaborative and collegial environment emphasizing innovation and meticulous attention to protocol compliance and data quality. Through these efforts, the BTTC will strive to advance treatments for patients with neuro-oncologic illness with recognition of the importance of merging good scientific method with concern for patient well-being and outcome.
Our goals include:
- To discover new and effective therapies for the treatment of patients with brain tumors, using surgically based strategies as well as systemic treatments, and new molecular agents such as gene therapy
- To develop innovative combination strategies to enhance the therapeutic effects of chemotherapy and radiation treatments
- To develop and fund translational research opportunities that will bring exciting new agents and strategies from the laboratory to the clinical setting